Thyroid Function, Cardiovascular Events, and Mortality in Diabetic Hemodialysis Patients

被引:58
作者
Drechsler, Christiane [1 ,2 ,3 ]
Schneider, Andreas [1 ,3 ]
Gutjahr-Lengsfeld, Lena [1 ,3 ]
Kroiss, Matthias [3 ,4 ]
Carrero, Juan Jesus [5 ,6 ]
Krane, Vera [1 ,3 ]
Allolio, Bruno [3 ,4 ]
Wanner, Christoph [1 ,3 ]
Fassnacht, Martin [3 ,4 ,7 ]
机构
[1] Univ Hosp, Dept Med 1, Div Nephrol, Wurzburg, Germany
[2] Univ Wurzburg, Univ Hosp, Inst Clin Epidemiol & Biometry, D-97070 Wurzburg, Germany
[3] Univ Wurzburg, Univ Hosp, Comprehens Heart Failure Ctr, D-97070 Wurzburg, Germany
[4] Univ Wurzburg, Univ Hosp, Endocrine & Diabet Unit, D-97070 Wurzburg, Germany
[5] Karolinska Inst, Div Renal Med, Stockholm, Sweden
[6] Karolinska Inst, Ctr Mol Med, Stockholm, Sweden
[7] Univ Munich, Med Klin & Poliklin 4, Munich, Germany
基金
瑞典研究理事会;
关键词
Thyroid disorder; cardiovascular disease; hemodialysis; subclinical thyroid dysfunction; diabetes; thyroid-stimulating hormone (TSH); thyrotropin; end-stage renal disease; CHRONIC KIDNEY-DISEASE; STAGE RENAL-DISEASE; LOW TRIIODOTHYRONINE; HEART-FAILURE; SUBCLINICAL HYPOTHYROIDISM; RISK-FACTOR; DYSFUNCTION; HORMONE; PREVALENCE; SURVIVAL;
D O I
10.1053/j.ajkd.2013.10.009
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Background: In dialysis patients, the prevalence of thyroid disorders and their impact on specific cardiovascular (CV) events and mortality are largely unknown. The aim of the present study was to analyze whether subclinical thyroid disorders were associated with CV events and mortality. Study Design: Prospective multicenter cohort study. Setting & Participants: Thyroid status and clinical outcomes were explored in 1,000 diabetic hemodialysis patients from 178 centers in Germany. Predictor: Thyroid status, defined by the following cutoff values: euthyroidism (thyrotropin [TSH], 0.30-4.0 mIU/L; free triiodothyronine [T-3], 2.7-7.6 pmol/L; and free thyroxine [T-4], 11.0-24.0 pmol/L), subclinical hyperthyroidism (TSH, 0.3 mIU/L and free T3/free T4 within reference ranges), subclinical hypothyroidism (TSH, 4.1-15.0 mIU/L and free T-3/free T-4 within reference ranges), euthyroid sick syndrome (free T3, 2.7 pmol/L and TSH/free T-4 low or within reference ranges). Outcomes: During 4 years' follow-up, prespecified adjudicated end points were determined: sudden cardiac death, myocardial infarction, stroke, combined CV events, and overall mortality. Short-term effects within the first 12 months were contrasted to long-term effects (years 2-4). Measurements: TSH, free T3(,) and free T-4 levels at baseline. Results: Euthyroidism was present in 78.1% of patients; subclinical hyperthyroidism, in 13.7%; and subclinical hypothyroidism, in 1.6%. Euthyroid sick syndrome was exhibited by 5.4% of patients. The adjusted short-term risk of sudden cardiac death was more than doubled (HR, 2.03; 95% CI, 0.94-4.36) in patients with subclinical hyperthyroidism, and similarly for patients with euthyroid sick syndrome (HR, 2.74; 95% CI, 0.94-7.98) compared with patients with euthyroidism. Short-term mortality was increased almost 3-fold for patients with euthyroid sick syndrome (HR, 2.97; 95% CI, 1.66-5.29), but this effect was not seen in the long term. Subclinical hypothyroidism was not associated with CV events or all-cause mortality. Risks of stroke and myocardial infarction were not affected meaningfully by thyroid disorders. Limitations: Observational study design. Conclusions: Sudden cardiac death may be influenced by subclinical hyperthyroidism and euthyroid sick syndrome in the short term. Furthermore, euthyroid sick syndrome is associated strongly with mortality in hemodialysis patients. Regular assessment of thyroid status may help estimate the cardiac risk of dialysis patients. (C) 2014 by the National Kidney Foundation, Inc.
引用
收藏
页码:988 / 996
页数:9
相关论文
共 33 条
  • [1] Thyroid status, cardiovascular risk, and mortality in older adults
    Cappola, AR
    Fried, LP
    Arnold, AM
    Danese, MD
    Kuller, LH
    Burke, GL
    Tracy, RP
    Ladenson, PW
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (09): : 1033 - 1041
  • [2] Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease
    Carrero, J. J.
    Qureshi, A. R.
    Axelsson, J.
    Yilmaz, M. I.
    Rehnmark, S.
    Witt, M. R.
    Barany, P.
    Heimburger, O.
    Suliman, M. E.
    Alvestrand, A.
    Lindholm, B.
    Stenvinkel, P.
    [J]. JOURNAL OF INTERNAL MEDICINE, 2007, 262 (06) : 690 - 701
  • [3] Prevalence of subclinical hypothyroidism in patients with chronic kidney disease
    Chonchol, Michel
    Lippi, Giuseppe
    Salvagno, Gianluca
    Zoppini, Giacomo
    Muggeo, Michele
    Targher, Giovanni
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (05): : 1296 - 1300
  • [4] Prevention of sudden cardiac death in patients with chronic kidney disease
    Franczyk-Skora, Beata
    Gluba, Anna
    Banach, Maciej
    Kozlowski, Dariusz
    Malyszko, Jolanta
    Rysz, Jacek
    [J]. BMC NEPHROLOGY, 2012, 13
  • [5] Prognostic impact of subclinical thyroid dysfunction in heart failure
    Frey, Anna
    Kroiss, Matthias
    Berliner, Dominik
    Seifert, Marina
    Allolio, Bruno
    Gueder, Guelmisal
    Ertl, Georg
    Angermann, Christiane E.
    Stoerk, Stefan
    Fassnacht, Martin
    [J]. INTERNATIONAL JOURNAL OF CARDIOLOGY, 2013, 168 (01) : 300 - 305
  • [6] Subclinical Thyroid Dysfunction and the Risk of Heart Failure Events An Individual Participant Data Analysis From 6 Prospective Cohorts
    Gencer, Baris
    Collet, Tinh-Hai
    Virgini, Vanessa
    Bauer, Douglas C.
    Gussekloo, Jacobijn
    Cappola, Anne R.
    Nanchen, David
    den Elzen, Wendy P. J.
    Balmer, Philippe
    Luben, Robert N.
    Iacoviello, Massimo
    Triggiani, Vincenzo
    Cornuz, Jacques
    Newman, Anne B.
    Khaw, Kay-Tee
    Jukema, J. Wouter
    Westendorp, Rudi G. J.
    Vittinghoff, Eric
    Aujesky, Drahomir
    Rodondi, Nicolas
    [J]. CIRCULATION, 2012, 126 (09) : 1040 - U100
  • [7] Thyroid status, disability and cognitive function, and survival in old age
    Gussekloo, J
    van Exel, E
    de Craen, AJM
    Meinders, AE
    Frölich, M
    Westendorp, RGJ
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2004, 292 (21): : 2591 - 2599
  • [8] The Hazards of Hazard Ratios
    Hernan, Miguel A.
    [J]. EPIDEMIOLOGY, 2010, 21 (01) : 13 - 15
  • [9] Serum TSH, T4, and thyroid antibodies in the United States population (1988 to 1994):: National Health and Nutrition Examination Survey (NHANES III)
    Hollowell, JG
    Staehling, NW
    Flanders, WD
    Hannon, WH
    Gunter, EW
    Spencer, CA
    Braverman, LE
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2002, 87 (02) : 489 - 499
  • [10] THE THYROID IN END-STAGE RENAL-DISEASE
    KAPTEIN, EM
    QUIONVERDE, H
    CHOOLJIAN, CJ
    TANG, WW
    FRIEDMAN, PE
    RODRIQUEZ, HJ
    MASSRY, SG
    [J]. MEDICINE, 1988, 67 (03) : 187 - 197